Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 7/20 | 0.35 |
| ▸ | METAP1 | P53582 | 6/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | FBP1 | P09467 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25766831 | 0.86 | TSHR (0.37) | BTN3A1ALDH1A1KDM4ETSHRGAA | |
| SCHEMBL12746452 | 0.84 | NPC1 (0.35) | BTN3A1ALDH1A1KDM4EMETAP2METAP1 | |
| SCHEMBL19225305 | 0.82 | MGAM (0.39) | BTN3A1ALDH1A1TSHRGAAMGAM | |
| SCHEMBL13633863 | 0.82 | MGAM (0.39) | BTN3A1ALDH1A1TSHRGAAMGAM | |
| SCHEMBL12746435 | 0.82 | MGAM (0.39) | BTN3A1ALDH1A1TSHRGAAMGAM | |
| SCHEMBL12746431 | 0.81 | BTN3A1 (0.39) | BTN3A1ALDH1A1GAAMGAMSI | |
| SCHEMBL21704579 | 0.81 | METAP2 (0.37) | BTN3A1GAAMGAMSIMGAM2 | |
| SCHEMBL21704812 | 0.80 | BTN3A1 (0.36) | BTN3A1GAAMGAMSIMGAM2 | |
| SCHEMBL22356079 | 0.80 | METAP2 (0.37) | BTN3A1ALDH1A1TSHRGAAMGAM | |
| SCHEMBL20181855 | 0.80 | TDP1 (0.39) | BTN3A1ALDH1A1TSHRGAAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018094275-A1 | ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS | TOLERO PHARMACEUTICALS, INC. (US) | 2018-05-24 | — | — | WO | disclosed |